Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

IL-15 exerts potent antiapoptotic effects in vivo

Oct. 27, 1997

Anti-H. pylori cephems claimed by Fujisawa

Oct. 24, 1997

Janssen discloses agents that promote gastrointestinal motility

Oct. 24, 1997

Promising clinical trial results reported for Medeva's Hepagene as vaccine and treatment

Oct. 23, 1997

Axcan completes phase III trial for H. pylori eradication

Oct. 22, 1997

OraVax to develop new treatments for Clostridium difficile-associated disease

Oct. 22, 1997

Diagnon receives NCI grant for H. pylori research

Oct. 17, 1997

Fujisawa launches new OTC product

Oct. 17, 1997

Schering-Plough extends collaboration with Pharmacopeia to include hepatitis

Oct. 14, 1997

ImmuCell receives grant to develop TravelGAM

Oct. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...